Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Reviews in Endocrine and Metabolic Disorders
Published in: Reviews in Endocrine and Metabolic Disorders 1/2018

01-03-2018

Approach to the interpretation of unexpected laboratory results arising in the care of patients with inborn errors of metabolism (IEM)

Authors: Andre Mattman, Murray Potter

Published in: Reviews in Endocrine and Metabolic Disorders | Issue 1/2018

Login to get access

Abstract

Endocrinologists may encounter abnormal results in routine laboratory tests while caring for patients with inborn errors of metabolism. This article provides a framework for understanding these abnormalities as: a) part of the pathophysiology of the exceptional disease, b) exceptional laboratory errors related to the exceptional disease, or c) routine laboratory errors to which any patient sample is susceptible.
Literature
1.
2.
Blau N, Duran M, Gibson KM, Vici CD, Blaskovics ME, editors. Physician’s guide to the diagnosis, treatment, and follow-up of inherited metabolic diseases. Heidelberg: Springer; 2014.
3.
Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA. Online Mendelian inheritance in man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 2005;33(suppl_1):D514–7.PubMed
4.
Lv H, Zhang GJ, Kang XX, Yuan H, Lv YW, Wang WW, et al. Factors interfering with the accuracy of five blood glucose meters used in Chinese hospitals. J Clin Lab Anal. 2013;27(5):354–66.CrossRef
5.
Mathew V, Ramakrishnan A, Srinivasan R, Sushma K, Bantwal G, Ayyar V. Erroneous glucose recordings while using mutant variant of quinoprotein glucose dehydrogenase glucometer in a child with galactosemia. Indian J Endocrinol Metab. 2013;17(Suppl 1):S289–91.CrossRef
6.
Warner JV, Wu JY, Buckingham N, McLeod DS, Mottram B, Carter AC. Can one point-of-care glucose meter be used for all pediatric and adult hospital patients? Evaluation of three meters, including recently modified test strips. Diabetes Technol Ther. 2011;13(1):55–62.CrossRef
7.
Radiometer ABL800 FLEX reference manual. 201206. Code number: 989–963, Version 6.10. Edition J. 2018.
8.
Ozbek MN, Ocal M, Tanriverdi S, Baysal B, Deniz A, Oncel K, et al. Capillary bedside blood glucose measurement in neonates: Missing a diagnosis of galactosemia. J Clin Res Pediatr Endocrinol. 2015;7(1):83–5.CrossRef
9.
Bayarchimeg M, Ismail D, Lam A, Burk D, Kirk J, Hogler W, et al. Galactokinase deficiency in a patient with congenital hyperinsulinism. JIMD Rep. 2012;5:7–11.CrossRef
10.
Tintu A, Rouwet E, Russcher H. Interference of ethylene glycol with (L)-lactate measurement is assay-dependent. Ann Clin Biochem. 2013;50(Pt 1):70–2.CrossRef
11.
Brindley PG, Butler MS, Cembrowski G, Brindley DN. Falsely elevated point-of-care lactate measurement after ingestion of ethylene glycol. CMAJ. 2007;176(8):1097–9.CrossRef
12.
Backes JM, Dayspring T, Mieras T, Moriarty PM. Pseudohypertriglyceridemia: Two cases of probable glycerol kinase deficiency. J Clin Lipidol. 2012;6(5):469–73.CrossRef
13.
Rahalkar AR, Hegele RA. Monogenic pediatric dyslipidemias: Classification, genetics and clinical spectrum. Mol Genet Metab. 2008;93(3):282–94.CrossRef
14.
Piketty ML, Polak M, Flechtner I, Gonzales-Briceno L, Souberbielle JC. False biochemical diagnosis of hyperthyroidism in streptavidin-biotin-based immunoassays: The problem of biotin intake and related interferences. Clin Chem Lab Med. 2017;55(6):780–8.CrossRef
15.
Elston MS, Sehgal S, Du Toit S, Yarndley T, Conaglen JV. Factitious Graves’ disease due to biotin immunoassay interference-A case and review of the literature. J Clin Endocrinol Metab. 2016;101(9):3251–5.CrossRef
16.
Li D, Radulescu A, Shrestha RT, Root M, Karger AB, Killeen AA, et al. Association of biotin ingestion with performance of hormone and nonhormone assays in healthy adults. JAMA. 2017;318(12):1150–60.CrossRef
17.
Samarasinghe S, Meah F, Singh V, Basit A, Emanuele N, Emanuele MA, et al. Biotin interference with routine clinical immunoassays: Understand the causes and mitigate the risks. Endocr Pract. 2017;23(8):989–98.CrossRef
18.
19.
Willeman T, Casez O, Faure P, Gauchez AS. Evaluation of biotin interference on immunoassays: New data for troponin I, digoxin, NT-Pro-BNP, and progesterone. Clin Chem Lab Med. 2017;55(10):e226–9.CrossRef
20.
Rulander NJ, Cardamone D, Senior M, Snyder PJ, Master SR. Interference from anti-streptavidin antibody. Arch Pathol Lab Med. 2013;137(8):1141–6.CrossRef
21.
Stibler H, Holzbach U, Kristiansson B. Isoforms and levels of transferrin, antithrombin, alpha(1)-antitrypsin and thyroxine-binding globulin in 48 patients with carbohydrate-deficient glycoprotein syndrome type I. Scand J Clin Lab Invest. 1998;58(1):55–61.CrossRef
22.
Walker V. Severe hyperammonaemia in adults not explained by liver disease. Ann Clin Biochem. 2012;49(Pt 3):214–28.CrossRef
23.
Houten SM, Violante S, Ventura FV, Wanders RJ. The biochemistry and physiology of mitochondrial fatty acid beta-oxidation and its genetic disorders. Annu Rev Physiol. 2016;78:23–44.CrossRef
24.
Sass JO. Inborn errors of ketogenesis and ketone body utilization. J Inherit Metab Dis. 2012;35(1):23–8.CrossRef
25.
Rahman SA, Nessa A, Hussain K. Molecular mechanisms of congenital hyperinsulinism. J Mol Endocrinol. 2015;54(2):R119–29.CrossRef
26.
Guven A, Cebeci N, Dursun A, Aktekin E, Baumgartner M, Fowler B. Methylmalonic acidemia mimicking diabetic ketoacidosis in an infant. Pediatr Diabetes. 2012;13(6):e22–5.CrossRef
27.
Hou JW. Biotin responsive multiple carboxylase deficiency presenting as diabetic ketoacidosis. Chang Gung Med J. 2004;27(2):129–33.PubMed
Metadata
Title
Approach to the interpretation of unexpected laboratory results arising in the care of patients with inborn errors of metabolism (IEM)
Authors
Andre Mattman
Murray Potter
Publication date
01-03-2018
Publisher
Springer US
Published in
Reviews in Endocrine and Metabolic Disorders / Issue 1/2018
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-018-9453-4

Other articles of this Issue 1/2018

Reviews in Endocrine and Metabolic Disorders 1/2018 Go to the issue

ReviewPaper

Not quite type 1 or type 2, what now? Review of monogenic, mitochondrial, and syndromic diabetes

EditorialNotes

When zebras run with horses – inherited metabolic diseases come mainstream

ReviewPaper

An overview of inborn errors of metabolism manifesting with primary adrenal insufficiency

ReviewPaper

Impact of pregnancy on inborn errors of metabolism

ReviewPaper

Hyperammonemia and lactic acidosis in adults: Differential diagnoses with a focus on inborn errors of metabolism

ReviewPaper

Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits